Recent Analyst Forecasts and Stock Ratings
Kalaris Therapeutics Inc. FAQ's
Kalaris Therapeutics Inc. has been rated by research analysts at Wedbush, Morgan Stanley, Raymond James, Chardan Capital, Piper Sandler in the past 90 days.
Kalaris Therapeutics Inc. has been rated by research analysts at Wedbush, Morgan Stanley, Raymond James, Chardan Capital, Piper Sandler in the past 90 days.